Aquashine vs Dermaheal: Korea's Amino-Acid and Peptide Skin Boosters Compared - A Complete Guide
Injectable skin boosters are sold by brand name, but the vial contents and the evidence behind them differ more than the marketing does. Photo: Zhang liven / Unsplash
Quick answer Aquashine and Dermaheal are two Korean-made injectable skin booster lines that combine hyaluronic acid with peptides and amino acids to target skin quality rather than volume. Neither is approved by the US Food and Drug Administration. Published evidence is stronger for plain injectable hyaluronic acid than for peptide-enriched "cocktail" formulations, and one systematic review found hyaluronic acid alone performed more strongly than the cocktails [1].
In this guide
What a skin booster actually is - and is not
"Skin booster" is a marketing category, not a regulatory one. It generally describes an injectable placed shallowly into the dermis across an area of skin, with the stated aim of improving hydration, texture, elasticity or radiance, rather than filling a fold or adding projection. That distinction matters because the clinical evidence base, the approval pathway and the risk profile all differ from volumising dermal fillers.
Most products in this category share a hyaluronic acid backbone. Where brands diverge is in what else is dissolved alongside it: amino acids, vitamins, nucleotides or short synthetic peptides. Korean clinics often group several of these under one menu heading, which is why patients arrive asking for "skin booster" and are then shown four or five brand names. The same confusion applies to the ECM and extracellular matrix injectables sold in the same treatment rooms.
What the Aquashine line is marketed as containing
Aquashine is produced by the Korean biotechnology company Caregen and is marketed as a non-crosslinked hyaluronic acid solution combined with synthetic biomimetic peptides. The line is sold in several variants, and clinics in Seoul commonly stock more than one of them.
Treat published ingredient summaries with care. Product composition for this category is set out on the manufacturer's own material and on distributor listings, not in a public regulatory database that a patient can search the way they can search an approved drug. There is no independent, patient-accessible registry that confirms, batch by batch, what is in a given vial. The practical consequence is that the most reliable account of what you are being injected with is the physical box and vial in front of you at the clinic - which is why the question list later in this guide asks you to see it.
What the Dermaheal line is marketed as containing
Dermaheal is also a Caregen line, and is usually presented as a mesotherapy range rather than a single product: different codes in the range are promoted for different concerns, and they are marketed as containing combinations of hyaluronic acid, amino acids, vitamins and peptides. Clinics frequently use Dermaheal codes in a multi-session course rather than as a one-off.
Because both lines come from the same manufacturer and share a hyaluronic-acid-plus-peptide architecture, a clinic recommending one over the other is usually making a judgement about which marketed indication fits your concern - not pointing to a head-to-head trial. As far as we were able to establish, no published head-to-head randomised comparison of these two specific brands exists. If a consultation presents one as clinically proven superior to the other, that is a claim worth asking for a citation on, in the same way you would when comparing two surgical plans in a second opinion.
Claim versus evidence: a side-by-side
The table below separates three things that get blurred in a consultation: what you will be told, what the published literature actually supports, and the question that closes the gap. It is deliberately not a price table - quoted prices for this category vary widely between clinics and between domestic and foreign patients.
Claim you are likely to hear | What published evidence supports | What to ask |
"This injectable improves skin quality." | A 2023 systematic review of 13 studies found injectable hyaluronic acid formulations improved measures including hydration, firmness, texture and elasticity, and judged the treatment reasonably safe with high patient satisfaction [1]. | Which measure improved in the studies you are citing, and over what period? |
"The added peptides make it work better than plain hyaluronic acid." | The same review reported that hyaluronic acid used alone showed a more pronounced effect than the combination "cocktail" preparations it examined [1]. That is the opposite of the usual sales direction. | Is there a trial comparing the cocktail against plain hyaluronic acid in patients like me? |
"You will see visible thickening of the skin." | In a 2024 study of 20 women using a hyaluronic acid and amino acid mesotherapy solution, histology showed significant change at three months while ultrasound showed no significant difference in dermal thickness at the sites measured [2]. | Is the improvement you are promising something I will see, or something only a biopsy would show? |
"It is used worldwide." | Being widely distributed is not the same as being approved. The FDA warns that no dermal filler is approved for over-the-counter use and advises patients not to buy injectables online, citing counterfeits and products not approved for US use [3]. | Is this product approved for sale in Korea, and can I see the packaging? |
Topical serums and injected skin boosters are often discussed in the same consultation, but they are regulated, priced and evidenced very differently. Photo: Content Pixie / Unsplash
Regulatory status outside Korea, and why it matters
Neither of these lines is an FDA-approved dermal filler in the United States. For a patient travelling to Korea, that is not automatically a red flag - many products are legitimately licensed in one market and not another, and Korea has its own regulatory system. It does have two practical consequences worth understanding before you book.
First, if you later have a complication at home, your own doctor may be unfamiliar with the product and unable to look it up in a domestic approvals database. Carrying the product name, the manufacturer and ideally a photograph of the packaging solves most of this. Second, the absence of a foreign approval removes a layer of independent review of the manufacturer's claims, which is one more reason to weigh marketing language carefully. The FDA's own guidance on injectables stresses that patients should not source these products themselves online, because counterfeit and unapproved material has been marketed [3].
Where these sit among treatments people actually book
It helps to see the scale of the wider category. The American Society of Plastic Surgeons reported that more than 28.5 million minimally invasive procedures were performed in 2024, against nearly 1.6 million cosmetic surgical procedures - more than double. Within that, neuromodulator injections accounted for 9,883,711 procedures and hyaluronic acid fillers for 5,331,426 [4].
Skin boosters are not broken out as their own line in those figures, which is itself informative: the category is commercially significant in Korea and across East Asia while remaining a smaller and less separately tracked segment elsewhere. If you are weighing a course of injections against a device-based option, the comparison between ultrasound lifting device generations runs on much the same logic - what is actually measured, over what period, and at what total cost once sessions are added up.
Side effects and the counterfeit problem
Injectable treatments placed in the dermis carry a recognised set of risks. The FDA lists bruising, redness, swelling, pain, tenderness, itching and rash as common effects of injectable fillers, with less common outcomes including inflammation, nodules or granulomas, infection and allergic reaction, and rare but serious events including vascular injury [3]. It also notes that some effects can appear weeks, months or years after injection, which is relevant if you will be back home by then.
A separate risk is product provenance. Counterfeit injectables have been marketed, and the FDA advises providers to inspect packaging for authenticity [3]. For a travelling patient the practical defence is simple and non-confrontational: ask to see the sealed box opened in front of you. A clinic that is comfortable doing this costs you nothing to ask; one that is not has told you something useful.
Before you agree to a course |
Ask for the total number of sessions and the total price in writing before the first injection, not the per-session price. Multi-session courses are where quoted costs and final costs most often diverge, and foreign-patient quoting practices vary between clinics. |
What to ask a Korean clinic before you book
A short, specific question list is more useful than trying to research every brand in advance. Ask which exact product and variant will be used, and to see the packaging. Ask who performs the injection and what their qualification is - you can verify a Korean specialist's board certification independently. Ask what the realistic, visible outcome is and over what timeframe, and what happens if you see nothing.
Then ask the commercial questions. How many sessions, at what total cost, and what is the policy if you return home partway through a course? Clinics differ substantially on this, and so do the quotes given to overseas and domestic patients - our guide on whether Korean clinics charge foreigners more sets out how to read a quote. Finally, ask what the clinic will give you in writing to take home: product name, batch where available, and the injection record. If a complication appears after you fly back, that document is what your own doctor will work from.
What the research says
Two studies are worth reading directly rather than through a clinic summary, because both contain findings that cut against the standard sales pitch for peptide-enriched skin boosters.
Hyaluronic acid alone outperformed the cocktails in a 2023 systematic review
Ghatge and Ghatge screened 2,996 articles and included 13 clinical studies of injectable hyaluronic acid formulations used in adults for facial skin quality, with the search running to 31 December 2022. Eight of the included studies evaluated hyaluronic acid alone and five evaluated hyaluronic acid combined with other active ingredients. All formulations significantly improved facial skin quality across measures including hydration, firmness, brightness, texture, radiance and elasticity, and the authors judged treatment quite safe with high patient satisfaction [1].
The finding that matters here: hyaluronic acid monotherapy showed a more pronounced effect than the cocktail preparations. Limitation: this was a systematic review without meta-analysis, the included studies were heterogeneous, and the authors explicitly state that large randomised controlled trials are still required. What it means for you: the presence of added peptides in a branded product is not, on current published evidence, a reason to expect a better result than a plain hyaluronic acid skin booster - and it is often a reason for a higher price.
Imaging and histology disagreed in a 2024 amino acid study
Scarano and colleagues treated 20 women, mean age 45 and range 35 to 64, at the University of Tirana in Albania, using an intradermal mesotherapy solution of low molecular weight hyaluronic acid fragments with nine amino acids, given in four sessions over eight weeks. Ultrasound and punch biopsies were taken before treatment and three months after [2].
Histology showed significant change: dermal thickness rose from 0.9 to 1.32 mm and epithelial thickness from 68.21 to 150.01 micrometres, with increased blood vessel counts. Ultrasound, however, showed no statistically significant difference in dermal thickness at the malar-cheek, chin or mandibular angle. Limitations stated by the authors include the small sample and the relatively low ultrasound frequency used; the study also had no control group. What it means for you: a product can produce real change at tissue level that does not translate into a difference you or a scanner can see. Ask what the clinic is promising you will actually notice.
Frequently asked questions
Is Aquashine or Dermaheal better?
There is no published head-to-head randomised trial between these two brands that we were able to identify, so any claim that one is clinically superior is currently a marketing position rather than an evidence-based one. Both are Caregen products built on a hyaluronic acid and peptide architecture, and the choice in practice usually reflects which marketed indication a clinic thinks fits your concern.
Are these products FDA-approved?
No. Neither line appears among FDA-approved dermal fillers. The FDA approves specific filler products for specific sites in adults aged 22 and over, warns that no dermal filler is approved for over-the-counter use, and advises patients not to buy injectables online because of counterfeit and unapproved material [3]. Being unapproved in the United States does not mean a product is unlawful in Korea, but it does mean no US review of the manufacturer's claims has taken place.
How many sessions will I need?
Clinics typically present these as a course rather than a single treatment, and the published mesotherapy study described above used four sessions over eight weeks [2]. Session counts in marketing material are not standardised across clinics, so the useful step is to get the total number and total price in writing before the first injection rather than agreeing per session.
What are the risks?
Common effects of injectable filler treatment listed by the FDA include bruising, redness, swelling, pain, tenderness, itching and rash. Less common outcomes include inflammation, nodules or granulomas, infection and allergic reaction, and rare events include vascular injury. Some effects can appear weeks, months or years later [3]. Discuss your own history with the treating doctor; this article is not a substitute for that conversation.
What should I take home with me?
Ask for the product name and manufacturer, the batch or lot number where the clinic can provide it, the number and dates of sessions, and the injection sites. If a delayed reaction occurs after you return home, a doctor unfamiliar with Korean-market products will need that information, and reconstructing it from memory months later is difficult.
References
Ghatge AS, Ghatge SB. The Effectiveness of Injectable Hyaluronic Acid in the Improvement of the Facial Skin Quality: A Systematic Review. Clinical, Cosmetic and Investigational Dermatology, 2023;16:891-899. PMID 37038447.
Scarano A, Qorri E, Sbarbati A, Gehrke SA, Frisone A, Amuso D, Tari SR. The efficacy of hyaluronic acid fragments with amino acid in combating facial skin aging: an ultrasound and histological study. Journal of Ultrasound, 2024;27:689-697. DOI 10.1007/s40477-024-00925-5.
US Food and Drug Administration. Dermal Fillers (Soft Tissue Fillers). FDA, Center for Devices and Radiological Health.
American Society of Plastic Surgeons. 2024 ASPS Procedural Statistics. ASPS press release, 25 June 2025.
Related reading
ECM Skin Boosters in Korea: What Extracellular Matrix Injectables Actually Do
Fat-Dissolving Injections in Korea: Comparing Kybella, Lemonbottle and Other Lipolysis Brands
Ultraformer MPT vs Doublo Gold: How Korean Ultrasound Lifting Device Generations Differ
Do Korean Clinics Charge Foreigners More? Domestic vs Foreign Patient Quotes
How to Verify a Korean Plastic Surgeon's Board Certification Before Surgery
About this guide. Korean Plastic Surgery Info is an independent information resource for international patients considering treatment in Korea. We do not operate, own or represent any clinic or hospital, and we receive no commission, referral fee or payment from any provider named or unnamed in this article. Brand names are used descriptively for identification only. This article summarises published literature and official regulatory guidance; it is not medical advice, does not establish a doctor-patient relationship, and should not be used to decide on treatment. Consult a qualified physician about your own circumstances. Sources were accessed and verified on 28 October 2026.
Comments